CODEMA PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of CODEMA PHARMA is 5.9% (elevated). The 2025 annual accounts show equity of €71,289 and a net result of -€32,963. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 30% of 12,464 sector peers (NACE 47, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry (see administrative flags).
History
Acts, filings and financial milestones
17-03
Gazette deed
Registered officeRegistered-office move2 facts ▸
- General meeting, “1º décembre 2025” (deed in French)
- Registered-office move, Rond-Point Schuman 2-4 (Levels 5 & 6, EU Quarter) à 1040 Bruxelles
Show earlier events
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.